Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NX-019 |
Trade Name | |
Synonyms | NX019|NX 019 |
Drug Descriptions |
NX-019 is a mutant-selective EGFR inhibitor with activity against EGFR exon 19 deletions, L858R, T790M, and exon 20 insertions, which potentially reduces tumor growth (Ann Oncol 2022, Vol 33, Suppl 9, Abstract # S1588). |
DrugClasses | EGFR Inhibitor (Pan) 62 |
CAS Registry Number | NA |
NCIT ID | C191849 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NX-019 | NX-019 | 0 | 1 |